Journal article
A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients
Abstract
PurposeTo test whether a multicomponent intervention would increase the use of low molecular weight heparin (LMWH) over unfractionated heparin (UFH) for venous thromboembolism (VTE) prophylaxis in critically ill patients and change patient outcomes and healthcare utilization.MethodsControlled pre–post trial of 12,342 adults admitted to 11 ICUs (five intervention, six control) May 1, 2015 to April 30, 2017 with no contraindication to …
Authors
Stelfox HT; Brundin-Mather R; Soo A; Parsons Leigh J; Niven DJ; Fiest KM; Doig CJ; Zuege DJ; Kushner B; Clement F
Journal
Intensive Care Medicine, Vol. 45, No. 2, pp. 211–222
Publisher
Springer Nature
Publication Date
2 2019
DOI
10.1007/s00134-019-05532-1
ISSN
0342-4642
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAnticoagulantsCritical IllnessEvidence-Based PracticeFemaleHeparin, Low-Molecular-WeightHumansImplementation ScienceIntensive Care UnitsInterrupted Time Series AnalysisLength of StayLogistic ModelsMaleMiddle AgedOdds RatioOutcome Assessment, Health CarePractice Patterns, Physicians'Pre-Exposure ProphylaxisRegistriesRetrospective StudiesVenous Thromboembolism